---
ticker: "BIB"
name: "ProShares Ultra Nasdaq Biotechnology"
url: "https://etf.net/etf/BIB"
grade: "C"
score: 54
graded_at: "2026-10-12"
category: "Leveraged Long (2x & Other)"
category_rank: "21 of 99"
methodology: "https://etf.net/methodology"
---

# BIB: ProShares Ultra Nasdaq Biotechnology

Grade **C**, Score 54 of 100. Rank 21 of 99 in Leveraged Long (2x & Other).

Graded Oct 12, 2026.

## Grade pillars

| Pillar | Score | Category rank |
| --- | --- | --- |
| Cost | 32 | 66 of 99 |
| Mission | Not scored | — |
| Risk | 66 | 19 of 96 |
| Tradability | 82 | 7 of 99 |
| Holdings | 56 | 11 of 23 |
| Durability | 75 | 11 of 99 |

## Top holdings

The fund holds 247 positions. These are the largest 30, by weight.

| # | Ticker | Name | Weight |
| --- | --- | --- | --- |
| 1 | — | Net Other Assets (Liabilities) | 18.94% |
| 2 | IQMM | Proshares Genius Mny Mkt Etf | 18.63% |
| 3 | GILD | Gilead Sciences Inc | 5.28% |
| 4 | AMGN | Amgen Inc | 4.99% |
| 5 | VRTX | Vertex Pharmaceuticals Inc | 4.78% |
| 6 | MRNA | Moderna Inc | 3.59% |
| 7 | REGN | Regeneron Pharmaceuticals | 3.24% |
| 8 | ILMN | Illumina Inc | 1.76% |
| 9 | RVMD | Revolution Medicines Inc | 1.75% |
| 10 | BIIB | Biogen Inc | 1.42% |
| 11 | ALNY | Alnylam Pharmaceuticals Inc | 1.28% |
| 12 | RPRX | Royalty Pharma Plc- Class A | 1.08% |
| 13 | ROIV | Roivant Sciences Ltd | 1.05% |
| 14 | UTHR | United Therapeutics Corp | 0.99% |
| 15 | INCY | Incyte Corp | 0.95% |
| 16 | ARGX | Argenx SE - Adr | 0.93% |
| 17 | GH | Guardant Health Inc | 0.92% |
| 18 | INSM | Insmed Inc | 0.90% |
| 19 | VTRS | Viatris Inc | 0.85% |
| 20 | MEDP | Medpace Holdings Inc | 0.73% |
| 21 | EXEL | Exelixis Inc | 0.62% |
| 22 | NBIX | Neurocrine Biosciences Inc | 0.60% |
| 23 | JAZZ | Jazz Pharmaceuticals PLC | 0.59% |
| 24 | ASND | Ascendis Pharma A/S | 0.59% |
| 25 | SMMT | Summit Therapeutics Inc | 0.57% |
| 26 | BBIO | Bridgebio Pharma Inc | 0.55% |
| 27 | HALO | Halozyme Therapeutics Inc | 0.53% |
| 28 | ONC | Beone Medicines Ltd-Adr | 0.53% |
| 29 | TEM | Tempus Ai Inc-Cl A | 0.50% |
| 30 | BNTX | Biontech Se-Adr | 0.47% |

Source: etf.net, https://etf.net/etf/BIB. Please cite the page URL.